Expression profiling in cancer using cDNA microarrays.
J Khan, L H Saal, M L Bittner...
https://pubmed.ncbi.nlm.nih.gov/10197427/Actively Recruiting
Led by National Cancer Institute (NCI) · Updated on 2026-10-16
6035
Participants Needed
5
Research Sites
N/A
Total Duration
Researchers are conducting a study to collect and store biological samples from children and adults diagnosed with common childhood cancers or adult cancers that share characteristics with pediatric malignancies. The study aims to create a tissue repository and perform comprehensive molecular, genomic, proteomic, metabolomic, and other advanced profiling techniques to better understand cancer biology and support related biological research. Participants may provide extra blood, serum, tissue, urine, or tumor samples during routine medical care or approved research procedures, with no additional invasive procedures solely for sample collection. The study also involves collecting previously obtained specimens and includes participants with a range of cancer diagnoses, suspected cancer susceptibility syndromes, their biological relatives, and healthy volunteers undergoing routine care or surgery. During the study, participants will undergo sample collection at times aligned with their routine care or research visits. Researchers will analyze these specimens using various advanced techniques, including DNA, RNA, and protein extraction, immune and stromal profiling, and cell population analyses. The study will also explore attitudes and beliefs about genetic testing related to pediatric cancer. The primary outcome is ongoing tissue analysis, with an expected enrollment of 100 to 150 patients annually.
CONDITIONS
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
D
Donna B Bernstein, R.N.
R
Rosandra N Kaplan, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Cancer Institute (NCI)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Ongoing
Participants provide extra blood, tissue, urine, or tumor samples during routine medical care or approved research procedures. No additional invasive procedures are performed solely for the study. Researchers analyze these samples using advanced molecular and genetic profiling techniques.
Sample collection occurs during routine care visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
J Khan, L H Saal, M L Bittner...
https://pubmed.ncbi.nlm.nih.gov/10197427/M S Linet, L A Ries, M A Smith...
https://pubmed.ncbi.nlm.nih.gov/10379968/J Khan, M L Bittner, Y Chen...
https://pubmed.ncbi.nlm.nih.gov/10214349/National Cancer Institute (NCI)
Lead Sponsor